179 related articles for article (PubMed ID: 26646122)
1. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
Borah BJ; Laughlin-Tommaso SK; Myers ER; Yao X; Stewart EA
Obstet Gynecol; 2016 Jan; 127(1):67-77. PubMed ID: 26646122
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.
Borah BJ; Yao X; Laughlin-Tommaso SK; Heien HC; Stewart EA
Obstet Gynecol; 2017 Nov; 130(5):1047-1056. PubMed ID: 29016510
[TBL] [Abstract][Full Text] [Related]
3. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
[TBL] [Abstract][Full Text] [Related]
4. The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids.
Martín-Merino E; García Rodríguez LA; Wallander MA; Andersson S; Soriano-Gabarró M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():147-52. PubMed ID: 26407334
[TBL] [Abstract][Full Text] [Related]
5. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
[TBL] [Abstract][Full Text] [Related]
6. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
[TBL] [Abstract][Full Text] [Related]
7. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit.
Geary RS; Gurol-Urganci I; Kiran A; Cromwell DA; Bansi-Matharu L; Shakespeare J; Mahmood T; van der Meulen J
BMJ Open; 2019 Feb; 9(2):e024260. PubMed ID: 30782899
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
10. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas.
Wegienka G; Stewart EA; Nicholson WK; Zhang S; Li F; Thomas L; Spies JB; Venable S; Laughlin-Tommaso S; Diamond MP; Anchan RM; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
J Womens Health (Larchmt); 2021 Mar; 30(3):355-366. PubMed ID: 33524308
[No Abstract] [Full Text] [Related]
11. Strong Association Between Endometriosis and Symptomatic Leiomyomas.
Nezhat C; Li A; Abed S; Balassiano E; Soliemannjad R; Nezhat A; Nezhat CH; Nezhat F
JSLS; 2016; 20(3):. PubMed ID: 27647977
[TBL] [Abstract][Full Text] [Related]
12. Alternatives to hysterectomy: The burden of fibroids and the quality of life.
Fortin C; Flyckt R; Falcone T
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():31-42. PubMed ID: 29157931
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
14. Use of medical, surgical and complementary treatments among women with fibroids.
Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
[TBL] [Abstract][Full Text] [Related]
15. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.
Taran FA; Weaver AL; Coddington CC; Stewart EA
Hum Reprod; 2010 May; 25(5):1177-82. PubMed ID: 20176591
[TBL] [Abstract][Full Text] [Related]
16. Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes.
Amoah A; Quinn SD
BJOG; 2023 Jun; 130(7):823-831. PubMed ID: 36706789
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40.
Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS
J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429
[TBL] [Abstract][Full Text] [Related]
18. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.
Mitro SD; Xu F; Lee C; Zaritsky E; Waetjen LE; Wise LA; Hedderson MM
Obstet Gynecol; 2024 May; 143(5):619-626. PubMed ID: 38547478
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas.
Nicholson WK; Wegienka G; Zhang S; Wallace K; Stewart E; Laughlin-Tommaso S; Thomas L; Jacoby VL; Marsh EE; Wise L; Borah BJ; Spies J; Venable S; Anchan RM; Larry Maxwell G; Diamond M; Lytle B; Myers ER
Obstet Gynecol; 2019 Aug; 134(2):261-269. PubMed ID: 31306318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
